Cognitive function in an elderly population with persistent impaired glucose tolerance

Diabetes Care

Volumn 21, Issue 3, 1998, Pages 398-402

  Vanhanen, Matti ^a   Koivisto, Keijo ^a   Kuusisto, Johanna ^a   Mykkänen, Leena ^a   Helkala, Eeva Liisa ^a   Hänninen, Tuomo ^a   Riekkinen, Paavo ^b   Soininen, Hilkka ^a   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; BLOOD GLUCOSE MONITORING; COGNITIVE DEFECT; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST;

AGE FACTORS; AGED; AGING; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; COGNITION; DIASTOLE; EDUCATIONAL STATUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REGRESSION ANALYSIS; SEX FACTORS; SYSTOLE;

EID: 0031888289     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.3.398     Document Type: Article

References (42)

1. Strachan MWJ, Deary IJ, Ewing FME, Frier BM: Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438-445, 1997
2. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D: Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 38:1096-1102, 1995
3. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
4. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
5. Jarrett RJ, Keen H, Fuller JH, McCartney M: Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia 16:25-30, 1979
6. King H, Zimmet P, Raper LR, Balkau B: The natural history of impaired glucose tolerance in the Micronesian population of Nauru: six year follow-up study. Diabetologia 26:39-43, 1984
7. Jarrett RJ, Keen H, McCartney P: The Whitehall Study: ten-year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and prediction of death. Diabet Med 1:279-283, 1984
8. Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM: Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? BMJ 301:397-402, 1990
9. Balkau B, Eschwège E, Papoz L, Richard JL, Claude JR, Warnet JM, Ducimetière P: Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 307:295-299, 1993
10. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
11. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
12. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
13. Feskens EJM, Kromhout D: Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Elderly Study. J Clin Epidemiol 45:1327-1334, 1992
14. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
15. DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 20 (Suppl. 11):S1-S6, 1992
16. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the haemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13:1865-1873, 1993
17. Erkinjuntti T, Hachinski VC: Rethinking vascular dementia. Cerebrovasc Dis 3:2-23, 1993
18. Kuusisto J, Koivisto K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Kervinen K, Kesäniemi YA, Riekkinen P Sr., Laakso M: Insulin resistance syndrome is associated with Alzheimer's disease independently of apolipoprotein E phenotype. BMJ 315:1045-1049, 1997
19. Mykkänen L, Laakso M, Uusitupa M, Pyörälä K: Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 13:1099-1105, 1990
20. Kuusisto J, Koivisto K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Riekkinen P, Laakso M: Essential hypertension and cognitive function: the role of hyperinsulinemia. Hypertension 22:771-779, 1993
21. Buschke H, Fuld PA: Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 24:1019-1025, 1974
22. Russell EW: A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 43:800-809, 1975
23. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271-276, 1958
24. Koivisto K, Helkala E-L, Reinikainen K, Hänninen T, Mykkänen L, Laakso M, Pyörälä K, Riekkinen P: Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests. J Geriatr Psychiatry Neurol 5:162-171, 1992
25. Borkowski JG, Benton AL, Spreen O: Word fluency and brain damage. Neuropsychologia 5:135-140, 1967
26. Butters N, Granholm E, Salmon DP, Grant I: Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol 9:479-497, 1987
27. Folstein MF, Folstein SE, McHugh PR: Minimental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975
28. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M: Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553-559, 1993
29. Vanhanen M, Koivisto K, Karjalainen L, Helkala E-L, Laakso M, Soininen H, Riekkinen P Sr.: Risk for non-insulin-dependent diabetes in the normoglycemic elderly is associated with impaired cognitive function. Neuroreport 8:1527-1530, 1997
30. Stolk RP, Breteler MMB, Ott A, Pols HAP, Lamberts SWJ, Grobbee DE, Hofman A: Insulin and cognitive function in an elderly population: the Rotterdam Study. Diabetes Care 20:792-795, 1997
31. Meyer JS, McClintic K, Rogers RL, Sims P, Mortel KF: Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 51:1489-1497, 1988
32. Baskin DG, Figlewicz DP, Woods SC, Porte D Jr., Dorsa DM: Insulin in the brain. Ann Rev Physiol 49:335-347, 1987
33. Brass BJ, Nonner D, Barret JN: Differential effects of insulin on choline acetyltransferase and glutamic acid decarboxylase activities in neuron-rich striatal cultures. J Neurochem 59:415-424, 1992
34. Kwok RPS, Juorio AV: Facilitating effect of insulin on brain 5-hydroxytryptamine metabolism. Neuroendocrinology 45:267-273, 1987
35. Sauter A, Goldstein M, Engel J, Ueta K: Effect of insulin on central catecholamines. Brain Res 260:330-333, 1983
36. Reinikainen KJ, Riekkinen PJ, Paljärvi L, Soininen H, Helkala E-L, Jolkkonen J, Laakso M: Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13:135-146, 1988
37. Gallagher M, Colombo PJ: Aging: the cholinergic hypothesis of cognitive decline. Curr Opinion Neurobiol 5:161-168, 1995
38. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB: Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397, 1996
39. Helkala E-L, Koivisto K, Hänninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkänen L, Kesäniemi YA, Laakso M, Riekkinen P Sr.: The association of apolipoprotein E polymorphism with memory: a population-based study. Neurosci Lett 191:141-144, 1995
40. Soininen HS, Riekkinen PJ Sr.: Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 19:224-228, 1996
41. Valdez R, Stem MP, Howard BV, Haffner SM: Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 18:993-1000, 1995
42. Uusitupa MIJ, Karhunen L, Rissanen A, Franssila-Kallunki A, Niskanen L, Kervinen K, Kesäniemi YA: Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am J Clin Nutr 64:131-136, 1996